Fagron N.V. | Mutual Funds
Mutual Funds that own Fagron N.V.
Evermore Global Value fund
1,397,621
1.95%
88,558
4.61%
03/31/2018
Midlin NV
1,140,822
1.59%
925,533
19.76%
09/30/2016
JPMorgan European Smaller Companies Trust Plc
1,067,420
1.49%
244,898
1.94%
02/28/2018
JPMorgan Funds - Europe Dynamic Small Cap Fund
975,329
1.36%
34,693
1.7%
05/31/2018
JPMorgan Funds - Europe Small Cap Fund
576,467
0.8%
24,681
1%
05/31/2018
Transamerica International Small Cap Value Fund
539,148
0.75%
19,500
1.18%
01/31/2018
JPMorgan Fund II ICVC - Europe Smaller Companies Fund
410,432
0.56%
0
2.38%
07/31/2018
BNP Paribas B - Pension Balanced
373,456
0.52%
0
0.19%
09/29/2017
Litman Gregory Masters International Fund
360,449
0.5%
9,202
1.12%
03/31/2018
BL - European Smaller Companies
272,400
0.38%
0
1.9%
07/31/2018
| Address |
Venecoweg 20A
Nazareth VL 9810
Belgium
|
|
Employees
|
- |
| Website |
http://www.fagron.com |
| Updated |
07/08/2019 |
| Fagron NV engages in the provision of development, marketing, and distribution of healthcare products and services. It operates through the following segments: Fagron Specialty Pharma Services (FSPS); Fagron Trademarks (FTM); Fagron Essentials (FE); and HL Technology. The FSPS segment refers to all personalized medication that is prepared in sterile and non-sterile compounding facilities in Europe, the United States, Colombia and South Africa. |
